Hedge Fund - Birchview Capital
Neurocrine Biosciences Inc (NBIX)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2021 - Q4 (2021-12-31) | $0 | 0% | 0 | $91.99 |
2 | 2021 - Q3 (2021-09-30) | $7,692,000 | 5.23% | 80,200 | $94.46 |
3 | 2021 - Q2 (2021-06-30) | $7,805,000 | 4.66% | 80,200 | $95.85 |
4 | 2021 - Q1 (2021-03-31) | $7,799,000 | 4.62% | 80,200 | $104.86 |
5 | 2020 - Q4 (2020-12-31) | $7,687,000 | 4.42% | 80,200 | $96.59 |
6 | 2020 - Q3 (2020-09-30) | $7,500,000 | 5.01% | 78,000 | $115.68 |
7 | 2020 - Q2 (2020-06-30) | $9,516,000 | 5.75% | 78,000 | $110.51 |
8 | 2020 - Q1 (2020-03-31) | $6,405,000 | 5.68% | 74,000 | $97.87 |
9 | 2019 - Q4 (2019-12-31) | $5,912,000 | 4.29% | 55,000 | $104.70 |
10 | 2019 - Q3 (2019-09-30) | $4,956,000 | 3.3% | 55,000 | $93.43 |
11 | 2019 - Q2 (2019-06-30) | $4,644,000 | 2.82% | 55,000 | $82.11 |
12 | 2019 - Q1 (2019-03-31) | $4,846,000 | 3.03% | 55,000 | $83.58 |
13 | 2018 - Q4 (2018-12-31) | $3,928,000 | 3.71% | 55,000 | $95.81 |
14 | 2018 - Q3 (2018-09-30) | $5,902,000 | 3.8% | 48,000 | $113.46 |
15 | 2018 - Q2 (2018-06-30) | $4,912,000 | 3.33% | 50,000 | $89.51 |
16 | 2018 - Q1 (2018-03-31) | $4,346,000 | 2.86% | 52,400 | $84.45 |
17 | 2017 - Q4 (2017-12-31) | $4,066,000 | 2.38% | 52,400 | $68.21 |
18 | 2017 - Q3 (2017-09-30) | $3,211,000 | 1.65% | 52,400 | $52.77 |
19 | 2017 - Q2 (2017-06-30) | $1,159,000 | 0.61% | 25,200 | $48.51 |
20 | 2017 - Q1 (2017-03-31) | $1,091,000 | 0.6% | 25,200 | $42.84 |
21 | 2016 - Q4 (2016-12-31) | $975,000 | 0.59% | 25,200 | $45.27 |
22 | 2016 - Q3 (2016-09-30) | $1,276,000 | 0.74% | 25,200 | $49.80 |
23 | 2016 - Q2 (2016-06-30) | $1,145,000 | 0.83% | 25,200 | $46.04 |
24 | 2016 - Q1 (2016-03-31) | $997,000 | 0.71% | 25,200 | $39.68 |
25 | 2015 - Q4 (2015-12-31) | $1,312,000 | 0.75% | 23,200 | $50.83 |
26 | 2015 - Q3 (2015-09-30) | $386,000 | 0.23% | 9,700 | $48.33 |
The displayed share prices are average quarterly stock market prices.